Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
Vani Lakshminarayanan, Pamela Thompson, Margreet A Wolfert, Therese Buskas, Judy M Bradley, Latha B Pathangey, Cathy S Madsen, Peter A Cohen, Sandra J Gendler, Geert-Jan Boons
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine'. Together they form a unique fingerprint.